$ 17 million had there been no unplanned shutdowns. Going forward, expected increase in PTA and PET capacities are likey to be absorbed in line with ongoing demand growth (expansion in PTA demand due to

issued ordinary shares, including, without limitation, (a) allocating the newly issued ordinary shares in a single offering or several offerings, (b) determining the offering period, offering price, as

Christi (1/3 ownership in JV)  Significant step forward in IVL value- creating strategy underpinning strong growth momentum  Creates new and exciting ways to serve our customer needs by expanding PTA-PET

production and earnings including new geographies. The quarter saw a spike in raw material prices, especially for paraxylene, which is expected to normalize going forward. Nevertheless, PET margins were

based on 12 month expected losses. For Stage 2 and Stage 3, the standard requires ECL allowances based on lifetime expected losses. Moreover, ECL also incorporates forward-looking economic scenarios into

our key products and strong margins, even carrying forward into the second quarter, driven at first by recovery in China. Global inventory levels are tight and combined with supply chain shocks are

indicating that rules or conditions to be waived are immaterial to the consideration of that case; (b) There is certain limitation under any other law causing the company unable to comply with rules or

1 August 17, 2018 Subject: Capital Increase for Offering for Sale to Specific Investors (Private Placement), Connected Transaction, Amendments to Articles of Association/Objectives of the Company and Determination of the Date of Extraordinary General Meeting of Shareholders No. 1/2018 To: President The Stock Exchange of Thailand Enclosures: 1. Information Memorandum on the Offering of Newly Issued Ordinary Shares to Specific Investors (Private Placement) at the Offering Price with a Discount of...

deployment strategies. All of this is in line with our imperatives towards becoming a world-class, well-diversified, growth-oriented global chemicals Company. Going forward, each of our segments necessitates

currency forward contracts 2 37 (19) N/A -152% 58 18 -70% Gain (loss) on foreign exchange 250 271 92 -63% -66% 335 363 9% Reversal of allowance for gain/(loss) from impairment of assets 0 (101) 19 N/A -118